NCT05156866
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05156866
Title First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors TORL Biotherapeutics, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Providence St. Jude Medical Center Fullerton California 92835 United States Details
UCLA - JCCC Clinical Research Unit Los Angeles California 90095 United States Details
Torrance Memorial Medical Torrance California 90505 United States Details
Fort Wayne Medical Oncology and Hematology Fort Wayne Indiana 46804 United States Details
Washington University School of Medicine-Siteman Cancer Center St Louis Missouri 63310 United States Details
Texas Oncology-Austin Austin Texas 78705 United States Details
Texas Oncology-Dallas Dallas Texas 75246 United States Details
START San Antonio San Antonio Texas 78229 United States Details
Texas Oncology-Tyler Tyler Texas 75702 United States Details
Seoul National University Hospital Seoul 03080 South Korea Details
Severance Hospital, Yonsei University Health System Seoul 03722 South Korea Details
Seoul National University Bundang Hospital Seoul 13620 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field